ArticleScientific reports2025
Female reproductive health trends and autism spectrum disorder prevalence between 2000 and 2024.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the correlation between female reproductive health parameters and Autism Spectrum Disorder (ASD) prevalence from 2000 to 2024. The analysis used advanced statistical and machine learning models to identify trends in key reproductive indicators and their association with ASD prevalence. Significant positive correlations were observed between ASD prevalence and maternal age, while negative correlations were found with antral follicle count, Anti-Müllerian Hormone (AMH) levels, and fertility rate. The Random Forest model emerged as the most accurate predictive tool, explaining 96.9% of the variance in ASD prevalence. Maternal age was the dominant predictor of the variables analyzed, contributing approximately 75% of the model's predictive power, while estradiol levels and Follicle Stimulating Hormone (FSH) contributed significantly less. These findings highlight potential statistical associations but do not establish causality. Further research is necessary to validate these associations and explore underlying biological mechanisms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.